和元生物：2025年年度业绩预亏公告

Core Viewpoint - He Yuan Bio announced an expected net profit attributable to the parent company for the year 2025 to be between -237 million to -195 million yuan, indicating a reduction in losses compared to the previous year [2] Financial Performance - The company anticipates a reduction in losses by 84.81 million to 126.81 million yuan, representing a decrease in loss margin of 26.35% to 39.41% compared to the same period last year [2] - The expected net profit attributable to the parent company, excluding non-recurring gains and losses, is projected to be between -244 million to -201 million yuan, with a reduction in losses of 91.91 million to 134.91 million yuan, reflecting a decrease in loss margin of 27.36% to 40.16% year-on-year [2]